BD - Earth day 2024

Myra Vision Reports Successful Initial Human Use of Calibreye™ System, a Next-Generation Aqueous Shunt Therapy for Moderate to Severe Glaucoma

Thursday, September 07, 2023

Myra Vision, a subsidiary of Shifamed, has commenced its inaugural clinical trial for the Calibreye™ System, an innovative device designed to manage intraocular pressure (IOP) in patients with moderate to severe glaucoma.

This prospective study, conducted without randomization and in an open-label fashion, seeks to evaluate the clinical procedure, safety, and overall performance of the Calibreye System in individuals with open-angle glaucoma.

The Calibreye System offers glaucoma specialists a means of regulating outflow, allowing for tailored therapy while minimizing potential complications. Once implanted, the Calibreye shunt permits non-invasive adjustments to outflow in a clinical setting, adapting to the changing treatment requirements of each patient.

In contrast to other glaucoma drainage devices, the adjustable outflow mechanism of the Calibreye System holds promise in achieving personalized and optimal IOP levels through straightforward in-office modifications.

Glaucoma, a leading cause of irreversible blindness, affects approximately 66 million people worldwide, with a significant portion of patients experiencing moderate to severe glaucoma requiring substantial reductions in IOP. Conventional treatment options for these patients have included surgical interventions such as trabeculectomy and tube shunt implants.

Although recent advancements in minimally invasive surgical devices have resulted in improved complication rates, attaining the necessary IOP reductions for patients with moderate to severe glaucoma remains a challenging endeavor. The implantation process of the Calibreye System aligns with well-established and familiar techniques in the field.



Healthcare CEO & Executive Strategy SummitHealthcare CNO SummitHealthcare CMO SummitHealthcare CFO, Financial Strategy & Revenue Cycle SummitThe Healthcare Patient Experience & Engagement Summit 2024Healthcare Innovation & Transformation Summit